Rigel Pharmaceuticals, Inc. (RIGL)
26.20
-0.47
(-1.76%)
USD |
NASDAQ |
May 07, 15:45
Rigel Pharmaceuticals SG&A Expense (TTM) : 88.18M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.56B |
| Nektar Therapeutics | 68.67M |
| Madrigal Pharmaceuticals, Inc. | 645.95M |
| Puma Biotechnology, Inc. | 70.85M |
| Xencor, Inc. | 63.64M |